Navigation Links
Benda Pharmaceutical Reports Fourth Quarter and Full Year 2007 Financial Results
Date:3/31/2008

HUBEI PROVINCE, China, March 31 /Xinhua-PRNewswire-FirstCall/ -- Benda Pharmaceutical, Inc. (OTC Bulletin Board: BPMA), a China-based pharmaceutical company producing both Gendicine(R), a commercialized gene therapy medicine for the treatment of cancer, and traditional Chinese and conventional medicines, today announced financial results for the fourth quarter and fiscal year ended December 31, 2007. The Company plans to file its Annual Report with the SEC today.

Full Year Ended December 31, 2007

Revenue in the fiscal year 2007 increased 66% to $26.4 million from $15.9 million in 2006. Revenue performance reflects increased sales from Benda's subsidiaries, Benda Ebei and Jiangling Benda, and approximately $5.8 million in revenue from Gendicine since Benda's acquisition of SiBiono in April 2007.

Gross profit during this period increased 97% to $12.5 million from $6.3 million in 2006. Gross margin increased 770 basis points to 47.3% from 39.6% in the same period of 2006, reflecting the higher margin revenue contribution from Gendicine sales.

The Company's general and administrative expenses in 2007 were $13.9 million compared to $2.5 million in 2006. The $11.4 million increase in 2007 was driven by $9.4 million in non-recurring costs, including $8.4 million in non-cash stock compensation expense for consulting services related to the acquisition of SiBiono and a $1.0 million cash penalty recorded in 2007 because of the late submission of the effective registration statement. For additional information regarding these items, please refer to the Company's Annual Report. Excluding these non-recurring expenses, operating income for the year 2007 would have been $5.8 million, up 92% from $3.0 million in 2006.

In 2007, Benda recognized $2.9 million in interest expense, related to the Company's convertible note issued in March 2007.

Mr. Charles Wan, Chief Executive Officer of Benda Pharmaceutical, commented, "We realized signi
'/>"/>

SOURCE Benda Pharmaceutical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Pharmaceutical Strategic Initiatives Adds Anne Sexton, MD, MS to Management Team
2. Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
3. Caraco Pharmaceutical Laboratories Ltd. To Market Generic Ethyol(R)
4. China Shenghuo Pharmaceutical Holdings, Inc. Schedules Conference Call to Discuss FY 2007 Results
5. Barr Pharmaceuticals, Inc. Executive Bios
6. Biotest Pharmaceuticals Corporation Responds to Orphan Drug Act Announcement
7. Tabula Rasa Strategies(TM), LLC, Announces Their Company Launch - A Clean Slate Approach to the Practice of Pharmaceutical Care
8. Honeywell Expands Aclar(R) Production for Pharmaceutical Industry
9. Surveys Find Key Changes in the Role of the Pharmaceutical CFO
10. KV Pharmaceutical Company Completes Financial Restatement with the Filing of Fiscal 2007 Form 10-K
11. AUDIO from Medialink and Solvay Pharmaceuticals: Men with Type 2 Diabetes at Increased Risk for Low Testosterone Should Talk to Their Doctors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015 The USC Verdugo Hills Hospital ... management for a decade with a current average healing rate ... USC and Wound Care Advantage to provide in-patient wound care. ... for a drop in the rate of hospital-acquired pressure ulcers ... is a complex undertaking that can frighten patients and caregivers ...
(Date:5/28/2015)... Falls Church, VA (PRWEB) May 28, 2015 ... Roadmap to the 351(k) Application Process, **FDAnews Webinar**, ... p.m. EDT, [http://www.fdanews.com/BiosimilarsApproval , On June ... and expertise of two leading intellectual property attorneys ... the webinar Success Strategies for Biosimilars Approval: A ...
(Date:5/28/2015)... 2015 Three years ago, Dr. Jeffrey Gosin ... Shore Vascular & Vein Center! Dr. Gosin’s center ... It is his mission to provide the highest quality care ... , Dr. Jeffrey Gosin is Board Certified in Surgery and ... Pennsylvania and Jefferson Medical College. He completed a General Surgery ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Ross A. ... surgeon , has hired Teresa Beard as the new ... her role, Beard will oversee all marketing and promotional ... of experience leading teams and developing compelling marketing strategies ... and Body Specialists, Beard served as guest communication manager ...
(Date:5/28/2015)... Boston Celtics Legend and Basketball Hall of ... Board of Directors members, will be hosting their 34th ... 4-7. For the past 34 years, the Havlicek’s have ... for children by bringing together friends, families, and celebrities ... Havlicek Celebrity Fishing Tournament will be held from June ...
Breaking Medicine News(10 mins):Health News:USC Verdugo Hills Hospital Wound Care Team Provides Outstanding Healing Results 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 3Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 2Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 3Health News:Clevens Face and Body Specialists Welcomes Teresa Beard as Marketing Director 2Health News:The Genesis Foundation Prepares for Their Final Annual John Havlicek Celebrity Fishing Tournament 2
... Loosening of Welfare Reform Rules Alter Longstanding System of ... Current versions of both the House and Senate health ... fail to prevent millions of illegal aliens from accessing ... Immigration Reform (FAIR). And in a radical change from ...
... protein implicated in rare form of bowel disorder, researchers ... with painful, chronic bowel conditions such as Crohn,s disease ... from new research. , Scientists say they,ve spotted a ... of colitis, and the finding might have implications for ...
... Inc. (Nasdaq: SGMO ) today reported third quarter 2009 ... ended September 30, 2009, Sangamo reported a consolidated net loss ... consolidated net loss of $6.3 million, or $0.15 per share, ... 2009, the company had cash, cash equivalents, marketable securities and ...
... ), the largest provider of deathcare products and services in North America, today reported results for ... end of this press release. The table below summarizes our key financial results: , , ... ... (In millions, except for September 30, ...
... drug makers, consumers, patients , WEDNESDAY, Nov. 4 (HealthDay ... designed to reduce preventable injuries and deaths caused by ... will focus on preventable injuries and deaths caused by ... attempts at self- harm," Dr. Janet Woodcock, director of ...
... Allergy and Infectious Diseases (NIAID), part of the National ... two programs that support research to better understand the ... including those that may be introduced into a community ... to the Cooperative Centers for Translational Research on Human ...
Cached Medicine News:Health News:Health Care Reform Legislation Becomes Vehicle for Reshaping Immigration Policy 2Health News:Health Care Reform Legislation Becomes Vehicle for Reshaping Immigration Policy 3Health News:Gene Discovery Gives Clues to Crohn's Disease, Colitis 2Health News:Gene Discovery Gives Clues to Crohn's Disease, Colitis 3Health News:Sangamo BioSciences Reports Third Quarter 2009 Financial Results 2Health News:Sangamo BioSciences Reports Third Quarter 2009 Financial Results 3Health News:Sangamo BioSciences Reports Third Quarter 2009 Financial Results 4Health News:Sangamo BioSciences Reports Third Quarter 2009 Financial Results 5Health News:Sangamo BioSciences Reports Third Quarter 2009 Financial Results 6Health News:Sangamo BioSciences Reports Third Quarter 2009 Financial Results 7Health News:Sangamo BioSciences Reports Third Quarter 2009 Financial Results 8Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 2Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 3Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 4Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 5Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 6Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 7Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 8Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 9Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 10Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 11Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 12Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 13Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 14Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 15Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 16Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 17Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 18Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 19Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 20Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 21Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 22Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 23Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 24Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 25
(Date:5/28/2015)... May 28, 2015 Zimmer Holdings, Inc. (NYSE ... finalized agreements with buyers to divest in ... Knee System assets, Biomet Discovery® Elbow System assets and ... furtherance of Zimmer,s pending acquisition of Biomet, Inc. ("Biomet").  ... to work constructively with the Bureau of Competition Staff ...
(Date:5/28/2015)... ZURICH , May 28, 2015  Maetrics ( ... the life sciences sector, wrapped up a successful conference, ... the Medical Technology industry," today in Zurich ... ( http://www.maetrics.ch ) and its Switzerland ... regulation on the Medical Technology field to an exclusive ...
(Date:5/28/2015)... YORK , May 28, 2015 ... ( http://www.morcellatorlawsuit2015.com )  in hysterectomies and myomectomies (procedures to ... indicates that the FBI is investigating Johnson & ... largest manufacturer of the devices. According to the ... May 27 th , the FBI is trying ...
Breaking Medicine Technology:Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 2Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 3Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 4Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 5Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 6Maetrics Hosts Innovative Medical Cluster Event in Switzerland 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 3
... July 25, 2011 A leading international scientist in ... ask their dentists about the potential for cross-contamination in ... that fasten patients, protective bibs in place. ... Dr. John Molinari, Director of Infection Control for ...
... Prasco Laboratories, the Authorized Generics company, announced today it has signed ... the terms of the agreement, Prasco will ... Generic version of Ponstel ® . Prasco ... Prasco label. "With the introduction of the authorized ...
Cached Medicine Technology:Question Your Dentist About Potential for Cross-Contamination, Leading Infection-Control Scientist Tells Fox News 2Prasco® Announces Authorized Generic Agreement with Shionogi Inc. 2
Indications For Usage: ,Pediatric (recommended tidal volume 70-250ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intend...
Indications For Usage: ,Adult (recommended tidal volume >150ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to...
... The Portex® Thermovent® T helps provide protection ... It is small and extremely lightweight making it ... adults. With a high rate of heat and ... secretion retention., ,All HMEs and filters have ...
... helps provide protection to the exposed airway of ... lightweight making it ideal for active young children ... of heat and moisture recovery, it ensures patient ... and filters have ISO standard tapered ends to ...
Medicine Products: